Enhabit, Inc. (NYSE:EHAB – Get Rating) gapped up prior to trading on Thursday . The stock had previously closed at $13.50, but opened at $14.18. Enhabit shares last traded at $13.13, with a volume of 5,744 shares.
Wall Street Analysts Forecast Growth
Separately, Bank of America started coverage on Enhabit in a report on Wednesday, July 13th. They issued an “underperform” rating and a $16.00 price target on the stock.
Enhabit Stock Performance
The company has a debt-to-equity ratio of 0.65, a current ratio of 1.41 and a quick ratio of 1.38.
Insider Buying and Selling at Enhabit
Hedge Funds Weigh In On Enhabit
A hedge fund recently bought a new stake in Enhabit stock. OLD Mission Capital LLC acquired a new stake in shares of Enhabit, Inc. (NYSE:EHAB – Get Rating) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 16,500 shares of the company’s stock, valued at approximately $379,000.
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
- Get a free copy of the StockNews.com research report on Enhabit (EHAB)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.